. 2008 Jun 25;28(26):6607–6615. doi: 10.1523/JNEUROSCI.4572-07.2008

Table 1.

Main effects in fMRI of fear conditioning (CS⁺ > CS⁻) in placebo and oxytocin groups and their interaction

	Placebo group			Oxytocin group			Difference placebo versus oxytocin group
	Coordinates	t value	p value	Coordinates	t value	p value	Coordinates	t value	p value
Dorsal/Ext Amy	18, 2, −8	3.68	<0.001				20, 0, −8	2.75	NS
Ant MTL							16, 8, −24	3.70	<0.05^*
R Insula	48, 4, 6	3.48	0.001
L Insula	−36, 16, −10	3.72	<0.001
vmPFC	14, 46, −10	3.50	0.001				16, 46, −10	3.66	0.001
vmPFC	20, 56, −6	3.77	<0.001
R lObfc	44, 54, −12	4.51	<0.001	20, 56, −6	5.00	<0.001
L lObfc							−40, 52, −6	3.80	<0.001
L ACC	−14, 14, 40	3.63	<0.001
R ACC	10, 10, 42	3.95	<0.001				10, 10, 44	4.75	<0.001
R rACC				−12, 34, 12	3.58	<0.001	6, 46, 16	3.57	<0.001
vlPFC	48, 46, 2	3.64	<0.001				−50, 32, 8	4.13	<0.001

Dorsal Amy, Dorsal amygdala; Ext Amy, extended amygdala; Ant MTL, anterior medial temporal lobe; vmPFC, ventromedial prefrontal cortex; vlPFC, ventrolateral prefrontal cortex; rACC, rostral anterior cingulate cortex; R, right; L, left; NS, nonsignificant. *Small volume corrected.